Molecular diagnostic company.
S 3404, VALID Act and regulation of pharmacogenomic tests. Issues related to S. 3404, VALID Act. Monitored issues related to the implementation of P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to S. 1895, the Lower Healthcare Cost Act including Surprise Medical Billing, issues related to H.R. 861, the End Surprise Billing Act, H.R. 5800, The Ban Surprise Billing Act; issues related to EKRA; H.R. 925 / H.R. 8406, The HEROES Act, issues related to COVID-19 testing and provider relief. H.R. 133, the Consolidated Appropriations Act of 2021, including surprise medical bill and COVID-19 testing. Issues related to access for veterans to pharmacogenomic testing for mental health. Issues related to implementation of S. 785, Commander John Scott Hannon Veterans Mental Health Care Improvement Act of 2019. Issues related to laboratory developed tests and reimbursement; issues related to the implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to the 2020 OPPS rule specifically related to packaging policy. Monitored issues related to H.R. 133, the Consolidated Appropriations Act of 2021, as it relates to surprise medical billing. Issues related to provider relief fund.
MED - Medical/Disease Research/Clinical Labs HCR - Health Issues VET - Veterans MMM - Medicare/Medicaid
34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
STACEY HUGHES EMILY PORTER MARY BETH SAVARY TAYLOR STACEY HUGHES MARY BETH SAVARY TAYLOR EMILY PORTER JEFF CHOUDHRY MARY BETH SAVARY TAYLOR EMILY PORTER STACEY HUGHES MARY BETH SAVARY TAYLOR EMILY PORTER